DANDELION and CANCER – Recent Research on Taraxacum Officinale since 2020 – 8 studies reviewed

 DR. WILLIAM MAKIS MD

JUN 12, 2024

∙ PAID

Papers Reviewed:

2020 (Jalili et al) – An Overview of Therapeutic Potentials of Taraxacum Officinale (Dandelion): A Traditionally Valuable Herb with a rich historical background

2020 (Xie et al) – Research Progress of Anti-tumor Active Ingredients in Dandelion

2020 (Wu et al) – Dandelion exerts anti-cancer effects in triple negative breast cancer (TNBC) by killing tumour cells via multiple cell death pathways

2021 (Venezuela et al) – Dandelion Root Extract Affects the Proliferation, Survival and Migration of Cervical Cancer Cell Lines

2023 (Liu et al) – Effect of dandelion polysaccharide on migration and invasion of triple-negative breast cancer cells based on PI3K/Akt/GSK-3β pathway

2023 (Stoutjesdyk et al) – In Vitro Anticancer effects of Taraxacum Genus Extracts: A Review

2024 (Kerry Yang et al) – Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking TLR4‑NFκB‑driven ACE2 and TMPRSS2 pathways

2024 June (Hua Gui et al) – Anti-tumor effect of dandelion flavone on multiple myeloma cells and its mechanism

Keep reading with a 7-day free trial

Subscribe to COVID Intel – by Dr.William Makis to keep reading this post and get 7 days of free access to the full post archives.

Start trial

Already a paid subscriber? Sign in